OSTX Long Term Debt from 2010 to 2024
OSTX Stock | 3.02 1.44 32.29% |
Long Term Debt | First Reported 2010-12-31 | Previous Quarter 11.9 M | Current Value 9.6 M | Quarterly Volatility 1.5 M |
Check OS Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OS Therapies' main balance sheet or income statement drivers, such as Interest Expense of 2.9 M, Selling General Administrative of 1 M or Total Revenue of 0.0, as well as many indicators such as . OSTX financial statements analysis is a perfect complement when working with OS Therapies Valuation or Volatility modules.
OSTX |
Latest OS Therapies' Long Term Debt Growth Pattern
Below is the plot of the Long Term Debt of OS Therapies Incorporated over the last few years. Long-term debt is a debt that OS Therapies has held for over one year. Long-term debt appears on OS Therapies Incorporated balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on OS Therapies Incorporated balance sheet is the sum of the balances of all categories of long-term debt. It is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. OS Therapies' Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OS Therapies' overall financial position and show how it may be relating to other accounts over time.
Long Term Debt | 10 Years Trend |
|
Long Term Debt |
Timeline |
OSTX Long Term Debt Regression Statistics
Arithmetic Mean | 7,779,828 | |
Geometric Mean | 7,663,732 | |
Coefficient Of Variation | 19.68 | |
Mean Deviation | 1,131,860 | |
Median | 7,072,415 | |
Standard Deviation | 1,531,039 | |
Sample Variance | 2.3T | |
Range | 4.8M | |
R-Value | 0.66 | |
Mean Square Error | 1.4T | |
R-Squared | 0.43 | |
Significance | 0.01 | |
Slope | 224,645 | |
Total Sum of Squares | 32.8T |
OSTX Long Term Debt History
Other Fundumenentals of OS Therapies
OS Therapies Long Term Debt component correlations
Click cells to compare fundamentals
About OS Therapies Financial Statements
OS Therapies investors use historical fundamental indicators, such as OS Therapies' Long Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OS Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Long Term Debt | 11.9 M | 9.6 M | |
Short and Long Term Debt | 13.1 M | 11.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.